George Scangos
Director/Board Member bei VOYAGER THERAPEUTICS, INC.
Vermögen: 44 Mio $ am 31.03.2024
Profil
George A. Scangos ist ein Geschäftsmann, der bereits 10 verschiedene Unternehmen geleitet hat und derzeit die Position des Präsidenten, Chief Executive Officer & Director bei Vir Biotechnology, Inc. innehat. Er ist außerdem Mitglied des National Board of Visitor an der University of California und im Vorstand von 5 weiteren Unternehmen. In seiner bisherigen Laufbahn hatte George A. Scangos die Position des Director bei Decibel Therapeutics, Inc. inne, Chief Executive Officer & Director bei Biogen, Inc. Chief Executive Officer bei Biogen Idec New Ventures, Inc. und Chief Executive Officer von Biogen Idec, Inc. (North Carolina) (beides Tochtergesellschaften von Biogen, Inc.), President, Chief Executive Officer & Director bei Exelixis, Inc., President für Bayer Biotechnology, Chairman von Anadys Pharmaceuticals, Inc. und Chairman des California Healthcare Institute, Senior Vice President-Research & Development bei Bayer, Inc. und President-Biotechnology Division bei Bayer Corp. sowie Chairman für Pharmaceutical Research & Manufacturers of America und Professor an der Johns Hopkins University. Er erhielt einen Doktortitel von der University of Massachusetts und einen Bachelor-Abschluss von der Cornell University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
2,83% | 26.02.2024 | 3 826 548 ( 2,83% ) | 39 Mio $ | 31.03.2024 |
15.03.2024 | 36 439 ( 0,01% ) | 5 Mio $ | 31.03.2024 |
Aktuelle Nachrichten zu George Scangos
Aktive Positionen von George Scangos
Unternehmen | Position | Beginn |
---|---|---|
VOYAGER THERAPEUTICS, INC. | Director/Board Member | 09.05.2023 |
VIR BIOTECHNOLOGY, INC. | Director/Board Member | 01.01.2017 |
AGILENT TECHNOLOGIES, INC. | Director/Board Member | 01.01.2011 |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA. | Director/Board Member | 12.07.2018 |
Biomedical Sciences Careers Program, Inc. | Director/Board Member | - |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Director/Board Member | - |
UC Davis School of Medicine | Corporate Officer/Principal | - |
IS Yatirim Menkul Degerler AS (Broker) | Analyst-Equity | - |
University of California | Corporate Officer/Principal | - |
░░░░ ░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Ehemalige bekannte Positionen von George Scangos
Unternehmen | Position | Ende |
---|---|---|
░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░ ░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von George Scangos
Cornell University | Undergraduate Degree |
University of Massachusetts | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
BIOGEN INC. | Health Technology |
AGILENT TECHNOLOGIES, INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
DECIBEL THERAPEUTICS, INC. | Health Technology |
VIR BIOTECHNOLOGY, INC. | Health Technology |
Private Unternehmen | 22 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Taconic Biosciences GmbH
Taconic Biosciences GmbH Miscellaneous Commercial ServicesCommercial Services Taconic Biosciences GmbH provides research in genetics and functional genomics. It specializes in the generation of genetic models for biomedical research and testing. The company was founded on October 5, 2001 and is headquartered in Leverkusen, Germany. | Commercial Services |
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada | Process Industries |
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
California Healthcare Institute | Health Technology |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Consumer Services |
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Health Technology |
IS Yatirim Menkul Degerler AS (Broker) | Finance |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Health Technology |
Biomedical Sciences Careers Program, Inc. | |
Fondation Santé | |
Baybio Institute | |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Octave Bioscience, Inc. operates as an early-stage diagnostics company which provides healthcare services. It focuses on neurodegenerative diseases and conditions. The company was founded by William A. Hagstrom in 2014 and is headquartered in Menlo Park, CA. | Health Services |
Bayer Biotechnology | |
Life Science Cares, Inc. | |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rezo Therapeutics, Inc. is a drug discovery company based in San Francisco, CA. The company's mission is to revolutionize traditional drug development by integrating proteomics, genetics, structural biology, chemistry, artificial intelligence, and machine learning to create maps of molecular disease networks. Rezo's initial focus is on oncology, but they plan to explore additional therapeutic areas through collaborations and partnerships. The company was founded by Natalia Jura, Kevan Shokat, Nevan Krogan, Sourav Bandyopadhyay, Norbert W. Bischofberger, and George A. Scangos, with Nevan Krogan serving as CEO since incorporation. | Commercial Services |